Home 9 EU Funding
ES logo

Biomapas & EU Funding

In March 2021 Biomapas started an EU funded project „mHealth solution for COVID-19 disease research, monitoring and treatment“.

The main aim of the project – to develop an innovative eHealth system for the research of COVID-19 disease.

During the project implementation period, Biomapas seeks to create electronic solutions for the effective and innovative COVID-19 disease process observation. The created prototype will be tested in a hybrid clinical trial to ensure effectiveness and safety.

Project implementation period: March 2021 – February 2022.
The project is co-financed by European Regional Development Fund up to € 1 000 000.

The project is funded as the EU response to the COVID-19 pandemic.


In July 2020, Biomapas started an EU-funded project of research and development activities by creating an artificial intelligence (AI) tool for pharmacovigilance services.

The main aim of the project – to create a pharmacovigilance system based on artificial intelligence.

Biomapas plans to commercialize the prototype of the technology created during the project in the form of a new pharmacovigilance service, ensuring continuous improvement of drug safety. It is planned that this service will be available on the market within a few months after completing the project. The company hopes that the new service will allow it to gain a fairly significant market share in the global market.

Project implementation period: July 2020 – August 2023.
The project is co-financed by European Regional Development Fund up to € 1 093 434,66.


In 2019, Biomapas started participating in the EU-funded project for international competitiveness strengthening by increasing awareness in foreign markets.

The project aims to increase the company’s awareness and further develop export activities by developing connections and partnerships with potential clients and partners from international conferences.

Project implementation period: July 2019 – October 2020. The project has been extended due to unforeseen global pandemic caused restrictions from October 2020 to 2022.

The project is financed by the EU structural fond “New opportunities LT”.

EU funding for the project: 45 000 Eur.


In January 2017, Biomapas became active in an EU-funded project of strengthening international competitiveness by raising awareness in foreign markets.

Biomapas attended eight International Events/Exhibitions to introduce its services to key market players for current cooperation and share business development strategies by creating relationships for future collaboration.

EU funding for the project was 50% of the costs.

Big Enough To Cover  All Your Needs. Small Enough To Care.

Discover the tailored solutions that Biomapas provides to accelerate your clinical trials and optimize your drug development process.

Clinical Research

Regulatory Affairs


Medical Information